George T John, DM, FRCP, FRACP
Royal Brisbane and Women's Hospital
1
0
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (1)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Jonathan Barratt, PhD, FRCP
University of Leicester
Shared therapeutic areas:
Worked with same sponsors:
Radko Komers, MD, PhD
Travere Therapeutics, Inc.
Shared therapeutic areas:
J. Bruce German, PhD
University of California, Davis
Shared therapeutic areas:
Ruben Poesen, MD
Universitaire Ziekenhuizen KU Leuven
Shared therapeutic areas:
Angela M Zivkovic, PhD
University of California, Davis
Shared therapeutic areas:
Rodrigo DM Plentz, PhD
Federal University of Health Sciences of Porto Alegre
Shared therapeutic areas:
Cheuk Chun Szeto, MD
Chinese University of Hong Kong
Shared therapeutic areas:
Denise Mafra, phd
Universidade Federal Fluminense
Shared therapeutic areas:
Junzhou Fu, MD
Department of Nephrology,1st People's Hospital of Guangzhou
Shared therapeutic areas:
Salvatore Febbraro, MD
Simbec Research
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy?
All 1 trials loaded